论文部分内容阅读
目的:对布地奈德混悬液联合肺力咳糖浆治疗小儿咳嗽变异性哮喘的可行性进行分析和探讨。方法:运用随机抽样的方法选择2012年12月到2014年12月在本院进行治疗的患者50例,随机将其分为观察组和对照组,两组各25例,对照组行布地奈德混悬液治疗(单一治疗),观察组行布地奈德混悬液联合肺力咳糖浆治疗(联合治疗)。结果:在治疗有效率上,观察组更高;在咳嗽时间等相关指标上,观察组更优;在不良反应率上,观察组更低。比较差异均具有统计学意义(P<0.01)。结论:布地奈德混悬液联合肺力咳糖浆治疗小儿咳嗽变异性哮喘具有较高的可行性,治疗效果更好,反应少,值得推广
OBJECTIVE: To analyze and discuss the feasibility of using budesonide suspension and cough syrup in the treatment of children with cough variant asthma. Methods: A random sample of 50 patients who were treated in our hospital from December 2012 to December 2014 were randomly divided into observation group (n = 25) and control group (n = 25). The control group received budesonide Suspension therapy (monotherapy), observation group budesonide suspension combined with cough syrup (combination therapy). Results: In the treatment efficiency, the observation group was higher; the observation group was better on the relevant indicators such as cough time; the observation group was lower on the adverse reaction rate. The differences were statistically significant (P <0.01). Conclusion: The combination of budesonide suspension and cough syrup in the treatment of pediatric cough variant asthma is more feasible and effective, with less reaction and worthy of promotion